Epithelial zinc finger protein in lung adenocarcinoma: prognostic biomarker with molecular and clinical implications

Abstract Objective This study aimed to evaluate the prognostic significance of epithelial zinc finger protein (EZF/KLF4) in lung adenocarcinoma (LAC) and explore its potential roles in tumor progression and immune regulation. Methods and Materials EZF expression and its associations with clinical ch...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaofen Wen, Jianling Zhu, Didi Xi, Minna Chen, De Zeng, Wenwu Xue, Danxia Lin, Jiaxin Shen
Format: Article
Language:English
Published: BMC 2025-06-01
Series:Hereditas
Subjects:
Online Access:https://doi.org/10.1186/s41065-025-00476-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849329514958553088
author Xiaofen Wen
Jianling Zhu
Didi Xi
Minna Chen
De Zeng
Wenwu Xue
Danxia Lin
Jiaxin Shen
author_facet Xiaofen Wen
Jianling Zhu
Didi Xi
Minna Chen
De Zeng
Wenwu Xue
Danxia Lin
Jiaxin Shen
author_sort Xiaofen Wen
collection DOAJ
description Abstract Objective This study aimed to evaluate the prognostic significance of epithelial zinc finger protein (EZF/KLF4) in lung adenocarcinoma (LAC) and explore its potential roles in tumor progression and immune regulation. Methods and Materials EZF expression and its associations with clinical characteristics were analyzed using TCGA and GEO datasets, and validated by immunohistochemistry in 25 paired LAC and adjacent normal tissues. Mechanistic insights were investigated through protein–protein interaction networks, gene set enrichment analysis (GSEA), DNA methylation profiling, and immune cell infiltration analysis via single-sample GSEA. A prognostic nomogram incorporating EZF expression, pT and pN stages, and residual tumor status was constructed using Cox regression modeling. Results EZF expression was significantly downregulated in LAC tissues compared to normal tissues across multiple cohorts (P < 0.001), yet paradoxically associated with advanced tumor stages and worse overall, disease-specific, and progression-free survival. Functional analyses revealed EZF-associated pathways enriched in immune modulation. EZF expression correlated strongly with infiltrating immune cells, including NK cells, eosinophils, mast cells, and neutrophils. Hypomethylation of the EZF promoter was linked to poor prognosis. The constructed nomogram exhibited strong predictive accuracy for patient outcomes. Conclusion EZF functions as a context-dependent regulator in LAC and may act as a prognostic biomarker by modulating tumor-immune interactions. These findings offer novel insights into the integration of molecular and immune features for personalized risk stratification and therapeutic guidance in LAC.
format Article
id doaj-art-dbea06f7df064042aafd2c2a9365ed37
institution Kabale University
issn 1601-5223
language English
publishDate 2025-06-01
publisher BMC
record_format Article
series Hereditas
spelling doaj-art-dbea06f7df064042aafd2c2a9365ed372025-08-20T03:47:14ZengBMCHereditas1601-52232025-06-01162111810.1186/s41065-025-00476-7Epithelial zinc finger protein in lung adenocarcinoma: prognostic biomarker with molecular and clinical implicationsXiaofen Wen0Jianling Zhu1Didi Xi2Minna Chen3De Zeng4Wenwu Xue5Danxia Lin6Jiaxin Shen7Department of Medical Oncology, Cancer Hospital of Shantou University Medical CollegeDepartment of Pathology, Cancer Hospital of Shantou University Medical CollegeDepartment of Oncology and Hematology, Dongguan Binhai Bay Central HospitalDepartment of Medical Oncology, Cancer Hospital of Shantou University Medical CollegeDepartment of Medical Oncology, Cancer Hospital of Shantou University Medical CollegeDepartment of Medical Oncology, Cancer Hospital of Shantou University Medical CollegeDepartment of Medical Oncology, Cancer Hospital of Shantou University Medical CollegeDepartment of Hematology, The First Affiliated Hospital of Shantou University Medical CollegeAbstract Objective This study aimed to evaluate the prognostic significance of epithelial zinc finger protein (EZF/KLF4) in lung adenocarcinoma (LAC) and explore its potential roles in tumor progression and immune regulation. Methods and Materials EZF expression and its associations with clinical characteristics were analyzed using TCGA and GEO datasets, and validated by immunohistochemistry in 25 paired LAC and adjacent normal tissues. Mechanistic insights were investigated through protein–protein interaction networks, gene set enrichment analysis (GSEA), DNA methylation profiling, and immune cell infiltration analysis via single-sample GSEA. A prognostic nomogram incorporating EZF expression, pT and pN stages, and residual tumor status was constructed using Cox regression modeling. Results EZF expression was significantly downregulated in LAC tissues compared to normal tissues across multiple cohorts (P < 0.001), yet paradoxically associated with advanced tumor stages and worse overall, disease-specific, and progression-free survival. Functional analyses revealed EZF-associated pathways enriched in immune modulation. EZF expression correlated strongly with infiltrating immune cells, including NK cells, eosinophils, mast cells, and neutrophils. Hypomethylation of the EZF promoter was linked to poor prognosis. The constructed nomogram exhibited strong predictive accuracy for patient outcomes. Conclusion EZF functions as a context-dependent regulator in LAC and may act as a prognostic biomarker by modulating tumor-immune interactions. These findings offer novel insights into the integration of molecular and immune features for personalized risk stratification and therapeutic guidance in LAC.https://doi.org/10.1186/s41065-025-00476-7EZF/KLF4Prognostic MarkerLung AdenocarcinomaTumor ImmunityNomogram
spellingShingle Xiaofen Wen
Jianling Zhu
Didi Xi
Minna Chen
De Zeng
Wenwu Xue
Danxia Lin
Jiaxin Shen
Epithelial zinc finger protein in lung adenocarcinoma: prognostic biomarker with molecular and clinical implications
Hereditas
EZF/KLF4
Prognostic Marker
Lung Adenocarcinoma
Tumor Immunity
Nomogram
title Epithelial zinc finger protein in lung adenocarcinoma: prognostic biomarker with molecular and clinical implications
title_full Epithelial zinc finger protein in lung adenocarcinoma: prognostic biomarker with molecular and clinical implications
title_fullStr Epithelial zinc finger protein in lung adenocarcinoma: prognostic biomarker with molecular and clinical implications
title_full_unstemmed Epithelial zinc finger protein in lung adenocarcinoma: prognostic biomarker with molecular and clinical implications
title_short Epithelial zinc finger protein in lung adenocarcinoma: prognostic biomarker with molecular and clinical implications
title_sort epithelial zinc finger protein in lung adenocarcinoma prognostic biomarker with molecular and clinical implications
topic EZF/KLF4
Prognostic Marker
Lung Adenocarcinoma
Tumor Immunity
Nomogram
url https://doi.org/10.1186/s41065-025-00476-7
work_keys_str_mv AT xiaofenwen epithelialzincfingerproteininlungadenocarcinomaprognosticbiomarkerwithmolecularandclinicalimplications
AT jianlingzhu epithelialzincfingerproteininlungadenocarcinomaprognosticbiomarkerwithmolecularandclinicalimplications
AT didixi epithelialzincfingerproteininlungadenocarcinomaprognosticbiomarkerwithmolecularandclinicalimplications
AT minnachen epithelialzincfingerproteininlungadenocarcinomaprognosticbiomarkerwithmolecularandclinicalimplications
AT dezeng epithelialzincfingerproteininlungadenocarcinomaprognosticbiomarkerwithmolecularandclinicalimplications
AT wenwuxue epithelialzincfingerproteininlungadenocarcinomaprognosticbiomarkerwithmolecularandclinicalimplications
AT danxialin epithelialzincfingerproteininlungadenocarcinomaprognosticbiomarkerwithmolecularandclinicalimplications
AT jiaxinshen epithelialzincfingerproteininlungadenocarcinomaprognosticbiomarkerwithmolecularandclinicalimplications